在过敏原免疫疗法中实现数字化,以人为本的护理 (PCC):一个ARIA-EAACI立场文件
Oliver Pfaar1, Bernardo Sousa-Pinto2,3, Nikolaos G Papadopoulos4
1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Allergy
|May 3, 2024
概括
移动健康 (mHealth) 应用程序有望改善针对鼻炎和喘的过敏原免疫疗法 (AIT) 中以人为本的护理 (PCC). 需要验证,但这些工具可以帮助AIT启动,有效性评估和治疗监测.
科学领域:
- 过敏和临床免疫学
- 数字健康数字健康
- 呼吸系统医学 呼吸系统医学
背景情况:
- 许多mHealth应用程序用于鼻炎和喘管理,但很少有经过严格的验证.
- 这些数字工具具有显著的潜力,可以在过敏原免疫疗法 (AIT) 中增强以人为本的护理 (PCC).
研究的目的:
- 在AIT中探索移动健康解决方案的临床应用和潜力.
- 在AIT中识别移动健康的当前局限性.
- 在数字AIT中提出临床实践和科学研究的未来发展建议.
主要方法:
- 审查现有的mHealth应用程序用于鼻炎和喘.
- 分析AIT启动,疗效评估和治疗监测中的潜在作用.
- 考虑数字生物标志物和共享决策框架.
主要成果:
- 移动健康应用程序可以支持患者选择和AIT启动的共享决策.
- 这些工具可以促进早期和持续治疗疗效的评估,包括停止规则.
- 数字生物标志物对于AIT未来的mHealth发展至关重要.
结论:
- 经过验证的mHealth解决方案为AIT的数字化PCC提供了一个有希望的途径.
- 进一步开发和验证对于充分实现mHealth在过敏护理方面的潜力至关重要.
- 需要确定和调整特定工具,以便在临床实践中有效实施.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Allergic Reactions
27.3K
Overview
27.3K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma: Pathogenesis and Management
390
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
390
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


